The James J. Lane,Jr., M.D. Endowed Lecture Series

 

The James J. Lane, Jr., M.D. Endowed Lecture Series was established to honor Dr. Lane’s contributions to the field of clinical rheumatology.  Dr. Lane was the first fellowship trainee in the fledgling Division of Arthritis at the University of Washington from 1958 to 1959. Each year on a Thursday in March, a lecture is held in honor of Dr. Lane as part of the Department of Medicine's Grand Rounds program.

Past Lane Lectures:

2009
Dan Kastner, MD
Chief of the Laboratory of Clinical Investigation, NIAMS
Clinical Director, NIAMS
Deputy Director, Intramural Clinical Research, NIH
Horror Autoinflammaticus: The Expanding Spectrum of Systematic Autoinflammatory Disease

2008
Dorian O. Haskard, MD
Sir John McMichael Professor of Cardiovascular Medicine, Imperial College London
Accelerated atherosclerosis in inflammatory rheumatic diseases

2007
Jonathan Atkinson, MD
Samuel B. Grant Professor of Medicine, Professor of Molecular Microbiology, Washington University
Not enough regulation of the innate immune response leading to human disease:  the examples of hemolytic uremic syndrome and age-related maculardegeneration 

2006
Lars Rönnblom, MD
Professor of Rheumatology, Department of Medical Science, University of Uppsala, Sweden
Systemic Lupus Erythematosus – an interferon driven disease with new therapeutic opportunities

2005
Steffen Gay, MD
Professor of Experimental Rheumatology and Leitender Arzt and Director of the WHO
Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic
Diseases at the University Hospital in Zurich, Switzerland
Molecular and Cellular Basis of Rheumatoid Joint Destruction

2004
Gary S. Firestein, MD
Professor of Medicine and Chief, Division of Rheumatology, Allergy and Immunology at the
University of California, San Diego
Evolving Concepts of Rheumatoid Arthritis.
 

2003
Bevra Hahn, MD
Professor of Medicine, Chief of Medicine, Division of Rheumatology, University of California Los Angeles
Potential for Inducing Suppressor T cells to Treat SLE: Lessons from a Murine Model

2002
William Arend, MD
Professor and Head, Rheumatology Division, University of Colorado
Inhibition of cytokines in the treatment of rheumatoid arthritis. 

David Isenberg, MD
Professor and Personal Chair in Rheumatology, University College of London
Do antibodies really cause disease? A lupus perspective.  

2001
Roland Moskowitz, MD
Professor of Medicine, Case Western University
Genetic associations of osteoarthritis